Dongsheng Pharmaceutical International Co. Ltd. (D
Post# of 250675

Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Dongsheng Pharmaceutical International Co. Ltd.
Fiscal year is July-June. All values USD millions. 2009 2010 5-year trend
Sales/Revenue - - - 17.13M 20.48M
Cost of Goods Sold (COGS) incl. D&A - - - 12.28M 15.17M
COGS excluding D&A - - - 12.27M 15.16M
Depreciation & Amortization Expense - - - 8,484 13,212
Depreciation - - - 8,484 13,212
Amortization of Intangibles - - - 0 0
Gross Income - - - 4.85M 5.31M
2009 2010 5-year trend
SG&A Expense - - - 1.65M 1.24M
Research & Development - - - 0 0
Other SG&A - - - 1.65M 1.24M
Other Operating Expense - - - 0 0
Unusual Expense - - - 0 0
EBIT after Unusual Expense - - - 0 0
Non Operating Income/Expense - - - (8,329) 1.35M
Non-Operating Interest Income - - - - -
Equity in Affiliates (Pretax) - - - 0 0
Interest Expense - - - 1,480 4,540
Gross Interest Expense - - - 1,480 4,540
Interest Capitalized - - - 0 0
Pretax Income - - - 3.19M 5.41M
Income Tax - - - 800,084 1.35M
Income Tax - Current Domestic - - - 378,748 994,450
Income Tax - Current Foreign - - - 0 0
Income Tax - Deferred Domestic - - - 421,336 360,472
Income Tax - Deferred Foreign - - - 0 0
Income Tax Credits - - - 0 0
Equity in Affiliates - - - 0 0
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income - - - 2.39M 4.06M
Minority Interest Expense - - - 0 0
Net Income - - - 2.39M 4.06M
Extraordinaries & Discontinued Operations - - - 0 0
Extra Items & Gain/Loss Sale Of Assets - - - 0 0
Cumulative Effect - Accounting Chg - - - 0 0
Discontinued Operations - - - 0 0
Net Income After Extraordinaries - - - 2.39M 4.06M
Preferred Dividends - - - 0 0
Net Income Available to Common - - - 2.39M 4.06M
EPS (Basic) - - - 0.15 0.25
Basic Shares Outstanding - - - 15.83M 16.14M
EPS (Diluted) - - - 0.15 0.25
Diluted Shares Outstanding - - - 15.83M 16.14M
EBITDA - - - 3.21M 4.08M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.

